CAR-T Cell Therapy in India
India has launched indigenous CAR-T cell therapy programs (NexCAR19 — the world's first indigenously developed CAR-T approved outside the USA/Europe), making this life-saving treatment accessible at $40,000–$70,000 vs $350,000–$500,000 in the USA.
Check Your Eligibility — Free
Send your reports. Our specialists will review and confirm whether CAR-T Cell Therapy is right for your case.
📋 Get Free Assessment| Cost Comparison | India | USA |
|---|---|---|
| CAR-T Cell Therapy | $40,000–$70,000 | $350,000–$500,000 |
| Savings | 60–80% less than USA | |
Conditions Treated with CAR-T Cell Therapy
- Relapsed/refractory B-cell non-Hodgkin lymphoma (r/r B-NHL)
- Relapsed/refractory B-cell acute lymphoblastic leukaemia (B-ALL)
- Diffuse large B-cell lymphoma (DLBCL) after 2+ prior lines
- Follicular lymphoma (grade 3B)
- Mantle cell lymphoma (investigational)
How CAR-T Cell Therapy Works (Step by Step)
- Eligibility assessment (CD19+/CD22+ tumour, organ function)
- T-cell collection by leukapheresis (Day -21)
- CAR-T cell manufacturing (2–3 weeks)
- Lymphodepleting chemotherapy (Flu/Cy)
- CAR-T cell infusion (Day 0)
- Monitoring for CRS and ICANS (14–21 days)
- Response assessment by PET-CT (Day 30–90)
Benefits of CAR-T Cell Therapy in India
- Complete remission in 40–60% of r/r DLBCL patients
- One-time treatment (no ongoing maintenance)
- Durable responses possible — some patients cured
- Indigenous Indian CAR-T 80% cheaper than imported products
Best Hospitals for CAR-T Cell Therapy in India
- AIIMS, New Delhi
- Tata Medical Center, Kolkata
- Christian Medical College, Vellore
- Apollo Cancer Centre, Chennai
- National Cancer Grid affiliated centres
Frequently Asked Questions
Q: How much does CAR-T cell therapy cost in India?
A: NexCAR19 (India's indigenous CAR-T) costs approximately $40,000–$70,000 for the full treatment, including manufacturing, conditioning chemotherapy, and monitoring. In the USA, Kymriah and Yescarta cost $350,000–$500,000 for the CAR-T product alone.